Variation in the management of thyroid cancer

J Clin Endocrinol Metab. 2013 May;98(5):2001-8. doi: 10.1210/jc.2012-3355. Epub 2013 Mar 28.

Abstract

Context: Little is known about practice patterns in thyroid cancer, a cancer that is increasing in incidence.

Objective: We sought to identify aspects of thyroid cancer management that have the greatest variation.

Design/setting/participants: We surveyed 944 physicians involved in thyroid cancer care from 251 hospitals affiliated with the US National Cancer Database. Physicians were asked questions in the following four domains: thyroid surgery, radioactive iodine use, thyroid hormone replacement postsurgery, and long-term thyroid cancer management. We calculated the ratio of observed variation to hypothetical maximum variation under the assumed distribution of the response. Ratios closer to 1 indicate greater variation.

Results: We had a 66% response rate. We found variation in multiple aspects of thyroid cancer management, including the role of central lymph node dissections (variation, 0.99; 95% confidence interval [CI], 0.98-1.00), the role of pretreatment scans before radioactive iodine treatment (variation, 1.00; 95% CI, 0.98-1.00), and all aspects of long-term thyroid cancer management, including applications of ultrasound (variation, 0.97; 95% CI, 0.93-0.99) and radioactive iodine scans (variation, 0.99; 95% CI, 0.97-1.00). For the management of small thyroid cancers, variation exists in all domains, including optimal extent of surgery (variation, 0.91; 95% CI, 0.88-0.94) and the role of both radioactive iodine treatment (variation, 0.91; 95% CI, 0.89-0.93) and suppressive doses of thyroid hormone replacement (variation, 1.00; 95% CI, 0.99-1.00).

Conclusion: We identified areas of variation in thyroid cancer management. To reduce the variation and improve the management of thyroid cancer, there is a need for more research and more research dissemination.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Combined Modality Therapy
  • Endocrinology
  • Female
  • Hormone Replacement Therapy
  • Humans
  • Iodine Radioisotopes / therapeutic use
  • Lymph Node Excision
  • Male
  • Medical Oncology
  • Medical Staff, Hospital
  • Middle Aged
  • Nuclear Medicine
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'*
  • Radionuclide Imaging
  • Radiopharmaceuticals / therapeutic use
  • Specialties, Surgical
  • Thyroid Neoplasms / diagnostic imaging
  • Thyroid Neoplasms / drug therapy
  • Thyroid Neoplasms / surgery
  • Thyroid Neoplasms / therapy*
  • United States
  • Voluntary Health Agencies
  • Workforce

Substances

  • Iodine Radioisotopes
  • Radiopharmaceuticals